MINIMABS

antibody-based therapeutic pharmaceutical and veterinary preparations comprising antibody fragments for use in cancer treatment, tumour therapy, modification of the biological activity of lymphokines and site specific targeting of biologically active substances for treatment of humans, domestic pets, livestock and wild animals